Back to top

EX-10.3 PRIVATE AND CONFIDENTIAL SEPARATION AND NON-DISCLOSURE AGREEMENT

NonDisclosure Agreement NDA

EX-10.3  PRIVATE AND CONFIDENTIAL

                     SEPARATION AND NON-DISCLOSURE AGREEMENT
 | Document Parties: KING PHARMACEUTICALS INC You are currently viewing:
This NonDisclosure Agreement NDA involves

KING PHARMACEUTICALS INC

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: EX-10.3 PRIVATE AND CONFIDENTIAL SEPARATION AND NON-DISCLOSURE AGREEMENT
Governing Law: Tennessee     Date: 3/21/2005
Industry: Biotechnology and Drugs     Sector: Healthcare

EX-10.3  PRIVATE AND CONFIDENTIAL

                     SEPARATION AND NON-DISCLOSURE AGREEMENT
, Parties: king pharmaceuticals inc
50 of the Top 250 law firms use our Products every day

 

<PAGE>

                                                                    EXHIBIT 10.3

 

                            PRIVATE AND CONFIDENTIAL

                     SEPARATION AND NON-DISCLOSURE AGREEMENT

 

         THIS AGREEMENT, dated the 13th day of July 2004, by and between King

Pharmaceuticals, Inc., a Tennessee corporation, having its offices at 501 Fifth

Street, Bristol, Tennessee ("Company") and Jefferson J. Gregory (hereinafter

referred to as "Mr. Gregory").

 

                                   WITNESSETH:

 

         WHEREAS, Mr. Gregory was employed by the Company as Chief Executive

Officer and served as Chairman of and as a director on the Company's Board of

Directors and as a director and officer of each of the Company's subsidiaries;

and

 

         WHEREAS, Mr. Gregory resigned from his employment with the Company as

Chief Executive Officer effective May 14, 2004; and

 

         WHEREAS, Mr. Gregory also resigned from his positions as Chairman of

and as a director on the Company's Board of Directors effective May 14, 2004,

and from his positions as a director and officer of each of the Company's

subsidiaries effective May 14, 2004; and

 

         WHEREAS, the Company is willing to provide monetary remuneration to Mr.

Gregory in return for certain covenants, agreements, releases and waivers all as

hereinafter set forth.

 

         NOW, THEREFORE, in consideration of the mutual agreements and covenants

hereinafter set forth, the parties agree as follows:

 

         1. Effective Date of Separation. The effective date of Mr. Gregory's

resignation from his position of Chief Executive Officer is May 14, 2004 (the

"Effective Date"). The effective date of Mr. Gregory's resignation from his

positions as Chairman and as a director on the Company's Board of Directors is

May 14, 2004. Further, the effective date of Mr. Gregory's resignation from his

positions as a director and officer of each of the Company's subsidiaries is May

14, 2004. The Company is accepting Mr. Gregory's resignation effective May 14,

2004 and agrees that Mr. Gregory shall continue to be covered by the Company's

health insurance until May 14, 2005 or until Mr. Gregory shall become eligible

for health care coverage through his employment with another entity, whichever

first occurs. Mr. Gregory shall have such rights as he may have under applicable

law to continue health coverage at his own expense for such additional periods

of time as is available under applicable law or to terminate such coverage or to

procure his own separate coverage as he may elect after his company health

coverage expires.

 

 

<PAGE>

 

         2. Consideration. Upon the full execution of this Agreement, the

Company shall pay to Mr. Gregory a lump sum which represents two (2) years of

his current annual salary and Target Bonus (80% of annual salary), as defined in

the Company's 2004 Management Incentive Plan, as adjusted pursuant to the terms

of this Paragraph 2 (the "Separation Payment"). The total gross amount due Mr.

Gregory is Two Million Three Hundred Forty Thousand Dollars ($2,340,000,000).

Applicable withholding taxes shall be deducted from such gross amount. However,

the Company will indemnify and reimburse Mr. Gregory for any additional future

excise taxes assessed by the Internal Revenue Service on the above Separation

Payment.

 

         3. Payment. The Separation Payment shall be fully due and payable to

Mr. Gregory upon the expiration of the seven (7) day revocation period set forth

in Paragraph 9 of this Agreement. Such payment in full shall be delivered by the

Company in the form of a check made payable to Mr. Gregory which shall be hand

delivered to Mr. Gregory, or by wire transfer to an account designated by Mr.

Gregory, at the expiration of said revocation period or as soon thereafter as

possible.

 

         4. Company Property. Also, in consideration of the payment of the

amount specified in Paragraph 2 above, Mr. Gregory agrees that all ideas,

inventions, trade secrets, know how, documents and data ("Creative Property")

developed either during, in connection with, or pursuant to his employment with

the Company or in connection with or pursuant to the terms and conditions of

this Agreement with the Company always have been and shall remain the exclusive

property of the Company. Mr. Gregory agrees to provide all reasonable assistance

to the Company in perfecting and maintaining its rights to Creative Property.

Mr. Gregory further agrees that the Company shall have the right to use the

Creative Property for any purpose without additional compensation to Mr.

Gregory. However, the Company agrees that if any such assistance is requested of

Mr. Gregory then the Company shall reimburse Mr. Gregory for his reasonable time

and expenses.

 

         Further, Mr. Gregory agrees to return and surrender possession of all

property of the Company, of any nature whatsoever, including but not limited to

keys, other methods of entry or access to the Company's physical premises,

identification badges, memoranda, notes, records, reports, computer hardware and

software, cellular phones and other communication devices, and any other Company

information, material, or equipment (or copies thereof) in Mr. Gregory's control

or possession as of the Effective Date of his resignation as set forth in

Paragraph 1 above.

 

         5. Confidential Information. Mr. Gregory agrees that he will not use or

disclose any confidential information, trade secret, or proprietary information,

whatever their form, obtained from or by virtue of his association with the

Company including but not limited to information about costs, profits, budgets,

finances, markets, sales, customers, potential customers, products,

formulations, pricing policies, operational methods or technical processes. Mr.

Gregory agrees not to communicate to any other person or entity about the

nature, quality or quantity of work. Mr. Gregory agrees not to display for any

purpose any document or portion thereof or any copy or reproduction

 

 

                                       2

<PAGE>

 

thereof, belonging to, or pertaining to the Company without due written

authorization from the Company. To the extent not inconsistent with this

Paragraph 5, nothing herein shall in any way prevent Mr. Gregory from utilizing

his general business, management and financial skills, techniques and abilities,

including any publicly available filings, documents or information concerning

the Company.

 

         6. Agreement Not to Compete. Mr. Gregory agrees that for a period of

twelve (12) months after the Effective Date of this Agreement he will not accept

any employment, whether as an owner, partner, director, officer, employee,

agent, independent contractor, consultant, or in any other capacity

(collectively referred to as "Employment" for purposes of this paragraph) with

any entity the business of which directly competes with the Company's business

in any geographical area in which the Company markets its products. Mr. Gregory

agrees and acknowledges that this provision will preclude him from accepting

Employment with any entity the business of which competes with any of the

products or business lines of the Company as they exist immediately prior to Mr.

Gregory's acceptance of such Employment. However, this provision will not

preclude Mr. Gregory from remaining employed by an entity that, subsequent to

the beginning of Mr. Gregory's Employment with such entity, becomes in

competition with the Company's business as the result of an expansion of the

scope of the Company's business. Should Mr. Gregory wish to accept Employment

with an entity whose business is not clearly outside the scope of the

restrictions provided for in this paragraph, Mr. Gregory must seek a

determination from the Chief Executive Officer of the Company and the

Compensation and Human Resources Committee of its Board of Directors and obtain

permission from the same to accept such Employment. The decision of the Chief

Executive Officer of the Company and the Compensation and Human Resources

Committee of its Board of Directors shall be delivered in writing to Mr. Gregory

within fourteen (14) business days. The Chief Executive Officer of the Company

and the Compensation and Human Resources Committee of its Board of Directors may

not unreasonably withhold such permission if said entity's business does not

directly compete with the Company's business as it exists at that time.

 

         7. Solicitation of the Company's Employees. Mr. Gregory agrees that for

a period of twenty-four (24) months from the Effective Date of this Agreement,

he will not participate in recruiting or soliciting any Company employee. Should

Mr. Gregory wish to discuss possible employment with any then-current Company

employee during the twenty-four (24) month period set forth above, he may

request permission to do so by seeking and obtaining a written exception to this

provision from the Chief Executive Officer of the Company and the Compensation

and Human Resources Committee of its Board of Directors; provided, however, Mr.

Gregory agrees that he will not discuss any employment possibility with such

employees prior to securing the Company's permission. Should the Company decline

to grant such permission, Mr. Gregory agrees that he will not at any time,

either during or after the non-solicitation period set forth above, advise the

employee concerned that he/she was the subject of a request under this paragraph

or that the Company refused to grant Mr. Gregory the right to discuss an

employment possibility with him/her.

 

 

                                       3

<PAGE>

 

         8. Covenant to Protect the Company. Mr. Gregory agrees: (i) not to make

any public statement or statements to the press concerning Company business

objectives, status of its securities, its management practices, or other

sensitive information without first receiving the Company's written approval;

(ii) that he will not divulge or disclose any proprietary or confidential

information to any third party, except his personal legal advisor, without the

prior written consent of the Company (any disclosure of such information by any

of Mr. Gregory's advisors shall be considered a disclosure by Mr. Gregory) (iii)

that he shall not make or publish any statement either orally or in writing

which he knows or reasonably should know may cause harm to the Company, its

Board of Directors, officers or its employees or agents.

 

         The Company agrees that the Company's directors and officers who are

subject to the reporting requirements of Section 16 of the Securities Exchange

Act of 1934 ("Section 16 Officers") will not make to any third party or any

employee of the Company, including without limitation the news media, any

written or oral statements critical of Mr. Gregory's character, integrity, or

job performance, or request any other person to do so.

 

         9. Release. Except for obligations of the Company arising under or

continuing pursuant to this Agreement, including specifically but not limited to

the provisions of Paragraph 10, Indemnification, Mr. Gregory hereby forever

waives for himself, his attorneys, heirs, executors, administrators, successors

and assigns fully and forever any claims against the Company, its partners, any

related or affiliated company (including, without limitation King

Pharmaceuticals, Inc., Monarch Pharmaceuticals, Inc., Jones Pharma Incorporated,

Parkedale Pharmaceuticals, Inc., King Pharmaceuticals Research and Development,

Inc., Meridian Medical Technologies, Inc., their predecessors, successors,

assigns, partners, officers, directors, agents, representatives, attorneys or

employees), for any action or inaction, loss, expense or any damages of whatever

nature arising from any occurrence or occurrences, known or unknown, from the

beginning of time until the Effective Date of this Agreement. Without

limitation, Mr. Gregory specifically waives any claim arising under the FAIR

LABOR STANDARDS ACT ("FLSA"), the AMERICANS WITH DISABILITIES ACT ("ADA"), the

AGE DISCRIMINATION IN EMPLOYMENT ACT ("ADEA"), and the REHABILITATION ACT (as

codified in 29 U.S.C. Sections 701 et seq.), or their state counterparts; claims

under TITLE VII OF THE CIVIL RIGHTS ACT OF 1964, as amended, TITLE VII OF THE

CIVIL RIGHTS ACT OF 1991, as amended, the FAMILY MEDICAL LEAVE ACT ("FMLA"), the

NATIONAL LABOR RELATIONS ACT ("NLRA"), or any state co


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more